Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Dec 29;48(3):953–964. doi: 10.3892/ijo.2015.3314

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © MikyŠková et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Combined chemoimmunotherapy of TC-1 or TRAMP-C2 tumors. (A) TC-1 (5×10⁴ cells) or TRAMP-C2 (10⁶ cells) tumor cells were s.c. transplanted on day 0. Docetaxel (DTX) was i.p. administered in a dose of 30 μg/kg, on days 7, 21 and 35. Dendritic cells (2×10⁶ cells) were s.c. administered peritumorally on days 14, 28 and 42. (B) Tumor growth (left panel) of TC-1 tumors and the percentage of tumor-free mice (Kaplan-Maier plot) (right panel). (C) Tumor growth (left panel) of TRAMP-C2 tumors and the percentage of tumor-free mice (right panel) (Kaplan-Maier plot). Results are representative of two independent experiments. ^*P<0.05 vs. control, ^xP<0.05 vs. DC/TRAMP-C2(HHP), DTX (analysis of variance).